111 Capital Invests $668,000 in Agilent Technologies, Inc. (NYSE:A)

111 Capital acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 4,976 shares of the medical research company's stock, valued at approximately $668,000.

A number of other institutional investors have also added to or reduced their stakes in A. Brighton Jones LLC grew its holdings in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after purchasing an additional 270 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of Agilent Technologies by 9.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 3,442 shares of the medical research company's stock valued at $462,000 after purchasing an additional 296 shares in the last quarter. PFG Investments LLC grew its holdings in shares of Agilent Technologies by 6.4% in the fourth quarter. PFG Investments LLC now owns 2,496 shares of the medical research company's stock valued at $335,000 after purchasing an additional 151 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Agilent Technologies by 18.0% in the fourth quarter. Blue Trust Inc. now owns 4,118 shares of the medical research company's stock valued at $611,000 after purchasing an additional 627 shares in the last quarter. Finally, KBC Group NV grew its holdings in shares of Agilent Technologies by 3.2% in the fourth quarter. KBC Group NV now owns 82,338 shares of the medical research company's stock valued at $11,062,000 after purchasing an additional 2,567 shares in the last quarter.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the business's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the transaction, the director now directly owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares of the company's stock, valued at $2,657,456.28. The trade was a 8.05% decrease in their ownership of the stock. The disclosure for this sale can be found here.

Analyst Upgrades and Downgrades

A has been the subject of a number of recent research reports. Jefferies Financial Group cut their target price on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a report on Monday, April 21st. Leerink Partners lifted their target price on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Friday. Barclays decreased their price objective on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. UBS Group decreased their price objective on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a report on Thursday. Finally, TD Cowen lifted their target price on Agilent Technologies to $150.00 and gave the company a "buy" rating in a research note on Thursday. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $140.15.

Agilent Technologies Stock Down 0.9%

Shares of A stock traded down $1.00 during trading hours on Monday, reaching $110.92. 1,757,003 shares of the company's stock were exchanged, compared to its average volume of 1,928,828. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The stock has a market cap of $31.62 billion, a PE ratio of 27.39, a PEG ratio of 3.40 and a beta of 1.23. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The stock's fifty day moving average price is $108.27 and its two-hundred day moving average price is $126.27.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. Agilent Technologies's revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.22 earnings per share. Research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be given a $0.248 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.89%. Agilent Technologies's dividend payout ratio is currently 24.44%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.